{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:26:36Z","timestamp":1786987596551,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:00:00Z","timestamp":1607126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ctro.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T04:21:43Z","timestamp":1607487703000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical"],"prefix":"10.1016","volume":"27","author":[{"given":"Sarah","family":"Stefanowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Wlodarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zschaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2020.12.001_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03376.x","article-title":"Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumor involvement within 1 mm of a resection margin","volume":"55","author":"Campbell","year":"2009","journal-title":"Histopathology"},{"issue":"16","key":"10.1016\/j.ctro.2020.12.001_b0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery of resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ctro.2020.12.001_b0015","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ctro.2020.12.001_b0020","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ijrobp.2012.02.051","article-title":"A phase I\/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer","volume":"84","author":"Ben-Josef","year":"2012","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2013.10.027","article-title":"Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer","volume":"110","author":"Wo","year":"2014","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2020.12.001_b0030","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi\u2010institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2016.05.010","article-title":"A phase 1 study of stereotactic body radiotherapy dose escalation for borderline resectable pancreatic cancer after modified FOLFIRINOX (NCT01446458)","volume":"96","author":"Shaib","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ctro.2020.12.001_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186341","article-title":"Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients","volume":"12","author":"Zschaeck","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctro.2020.12.001_b0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/0284186X.2016.1245862","article-title":"Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*","volume":"56","author":"Huguet","year":"2017","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2020.12.001_b0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation","volume":"94","author":"Krishnan","year":"2016","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2011.12.029","article-title":"A phase I\/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis","volume":"103","author":"Terashima","year":"2012","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2020.12.001_b0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.14338\/IJPT.14-00006.1","article-title":"Proton therapy and concomitant caspecitabine for non-metastatic unresectable pancreatic adenocarcinoma","volume":"1","author":"Sachsman","year":"2014","journal-title":"Int J Particle Ther"},{"issue":"3","key":"10.1016\/j.ctro.2020.12.001_b0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/0284186X.2012.762997","article-title":"Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity","volume":"52","author":"Nichols","year":"2013","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2020.12.001_b0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2020.12.001_b0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0360-3016(00)00522-8","article-title":"The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors","volume":"48","author":"Zurlo","year":"2000","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2011.05.045","article-title":"Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer","volume":"83","author":"Nichols","year":"2012","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.meddos.2013.11.005","volume":"39","author":"Ding","year":"2014","journal-title":"Med Dosim"},{"issue":"8Part1","key":"10.1016\/j.ctro.2020.12.001_b0095","doi-asserted-by":"crossref","first-page":"081711","DOI":"10.1118\/1.4887797","article-title":"A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas: Proton dosimetry in pancreatic cancer","volume":"41","author":"Thompson","year":"2014","journal-title":"Med Phys"},{"issue":"4","key":"10.1016\/j.ctro.2020.12.001_b0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1088\/0031-9155\/53\/4\/014","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculation uncertainties","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.ctro.2020.12.001_b0105","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1088\/0031-9155\/53\/4\/015","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2016.09.012","article-title":"Abdominal organ motion during inhalation and exhalation breath-holds: pancreatic motion at different lung volumes compared","volume":"121","author":"Lens","year":"2016","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2020.12.001_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/acm2.12613","article-title":"Comparison of pancreatic motion management with three abdominal corsets for particle radiation therapy: case study","volume":"20","author":"Dolde","year":"2019","journal-title":"J Appl Clin Med Phys"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13014-018-1165-0","article-title":"Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer","volume":"13","author":"Stefanowicz","year":"2018","journal-title":"Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.ctro.2020.12.001_b0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"10.1016\/j.ctro.2020.12.001_b0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index conformity of radiosurgical treatment plans","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.ctro.2020.12.001_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0958-3947(01)00072-3","article-title":"Comparative treatment planning between proton and x-ray therapy in pancreatic cancer","volume":"26","author":"Hsiung-Stripp","year":"2001","journal-title":"Med Dosim"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2003.11.019","article-title":"Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer","volume":"59","author":"Ben-Josef","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2020.12.001_b0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.21037\/jgo.2018.03.14","article-title":"Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer","volume":"9","author":"Chuong","year":"2018","journal-title":"J Gastrointest Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ctro.2020.12.001_b0150","doi-asserted-by":"crossref","first-page":"S564","DOI":"10.1016\/S0167-8140(21)01080-X","article-title":"PO \u2013 1063: Do we need a PTV around the boost in simultaneously integrated boost approaches of abdominal tumors?","volume":"152","author":"Stefanowicz","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2020.12.001_b0155","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2011.09.022","article-title":"Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic cancer","volume":"83","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2017.02.005","article-title":"Predictors of radiation therapy-related gastrointestinal toxicity from anal cancer dose-painted intensity modulated radiation therapy: secondary analysis of NRG Oncology RTOG 0529","volume":"98","author":"Olsen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2020.12.001_b0165","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijrobp.2017.08.006","article-title":"A novel absorbable radiopaque hydrogel spacer to separate the head of the pancreas and duodenum in radiation therapy for pancreatic cancer","volume":"99","author":"Rao","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2020.12.001_b0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jso.25495","article-title":"Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma","volume":"120","author":"Komatsu","year":"2019","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2020.12.001_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/0284186X.2018.1529424","article-title":"Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial","volume":"58","author":"Eekers","year":"2019","journal-title":"Acta Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082030104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082030104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:07:14Z","timestamp":1762502834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082030104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"alternative-id":["S240563082030104X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2020.12.001","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}